Skip to content
Screener

Clover Health Investments CLOV Q1 2026 earnings

Reported May 6, 2026 · After market close

Revenue$749.2MBeat by $34.3M
EPS$0.07In line
Revenue estimate$714.9M
EPS estimate$0.07

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$740.3M
EPS estimate-$0.01

Financials

Q1 2026

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05—

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$923.41M-49.7%
P/S0.4×-0.8×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp

Returns & leverage

See full
Return on equity-16.9%-170pp
Current ratio1.3×-0.2×

Segments

By segment

See full
Insurance segment$20.4M—

FAQ

When did Clover Health Investments report Q1 2026 earnings?
Clover Health Investments (CLOV) reported Q1 2026 earnings on May 6, 2026 after market close.
What were Clover Health Investments's Q1 2026 revenue and EPS?
Clover Health Investments reported revenue of $749.2M and eps of $0.07 for Q1 2026.
Did Clover Health Investments beat estimates in Q1 2026?
Revenue beat the consensus estimate of $714.9M by $34.3M. EPS beat the consensus estimate of $0.07 by $0.00.
How did Clover Health Investments's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 62.0% from $462.3M a year earlier and eps grew 40.0% from $0.05.
Where can I find Clover Health Investments's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001801170-26-000114) and the 10-Q periodic report (0001801170-26-000122) directly on SEC EDGAR. The filing index links above go to sec.gov.